Eleftheria Zeggini
From Wikipedia, the free encyclopedia
Ele Zeggini | |
|---|---|
| Born | |
| Alma mater | |
| Awards | Suffrage Science award (2014) |
| Scientific career | |
| Fields | Digital health Human genetics[2] |
| Institutions | |
| Thesis | Genetic dissection of the major histocompatibility complex in juvenile oligoarthritis (2002) |
| Website | www |
Eleftheria Zeggini (Greek: Ελευθερία Ζεγγίνη) is a director of the institute of translational genomics in Helmholtz Zentrum München and a professor at the Technical University of Munich (TUM).[4][2][5] Previously she served as a research group leader at the Wellcome Trust Sanger Institute from 2008 to 2018[6][7] and an honorary professor in the department of health sciences at the University of Leicester in the UK.[8][9][10][11]
Zeggini was educated at the University of Manchester Institute of Science and Technology (UMIST) where she was awarded a Bachelor of Science degree in Biochemistry in 1999. She continued her studies on the immunogenetics of the major histocompatibility complex in childhood arthritis at the Arthritis Research UK epidemiology unit at the University of Manchester, and was awarded a PhD in 2002.[12][13]
